Moreover, microarray-based gene expression analyses of MDA-MB-231 breast cancer cells revealed a downregulation of genes involved in the uPA/uPAR pathway upon SAM treatment, suggesting the possible epigenetic modulation of the axis in cancer [80]. The gene discussed is PLAU; the disease is cancer.